CONDENSED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenues	$ 2,021,707	$ 750,325	$ 5,660,662	$ 1,157,930
Cost of sales	1,226,911	430,683	2,885,008	620,196
Gross Profit	794,796	319,642	2,775,654	537,734
Operating Expenses:
General and administrative	2,535,477	626,605	8,183,236	1,782,926
Professional fees	247,813	254,532	2,244,804	958,436
Research and development	777,036		2,115,367
Sales and marketing	1,034,004	16,242	1,813,069	32,751
Total Operating Expenses	4,594,330	897,379	14,356,476	2,774,113
Loss from Operations	(3,799,534)	(577,737)	(11,580,822)	(2,236,379)
Other Income (Expense):
Interest income (expense)	3,834	(275)	12,850	(275)
Paycheck protection program loan forgiveness			108,532
Loss on disposal of fixed assets		(594)	(3,712)	(594)
Other income, net	24,798		83,548
Total Other Income (Expense)	28,632	(869)	201,218	(869)
Loss Before Income Taxes	(3,770,902)	(578,606)	(11,379,604)	(2,237,248)
Provision for income taxes
Net Loss	(3,770,902)	(578,606)	(11,379,604)	(2,237,248)
Deemed dividend on Series C Preferred stock and Series D warrants				(4,050,838)
Deemed dividend on redemption of Series D Preferred stock				(3,763,591)
Deemed dividend on issuance and repurchase of Series E Preferred stock				(1,227,120)
Series D Preferred stock dividends				(69,778)
Net Loss Available to Common Stockholders	$ (3,770,902)	$ (578,606)	$ (11,379,604)	$ (11,348,575)
Net Loss Per Common Share - Basic and Diluted	$ (0.05)	$ (0.01)	$ (0.17)	$ (0.33)
Weighted Average Number of Shares Outstanding During the Period -- Basic and Diluted	75,144,113	55,380,250	68,243,666	34,722,816